Citadel Advisors’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.4K | Sell |
10,345
-12,796
| -55% | -$74.7K | ﹤0.01% | 5418 |
|
|
2025
Q1 | $152K | Buy |
+23,141
| New | +$152K | ﹤0.01% | 4989 |
|
|
2024
Q1 | – | Sell |
-632
| Closed | -$13.9K | – | 6810 |
|
|
2023
Q4 | $13.9K | Buy |
632
+444
| +236% | +$9.75K | ﹤0.01% | 5468 |
|
|
2023
Q3 | $4.43K | Buy |
+188
| New | +$4.43K | ﹤0.01% | 5536 |
|
|
2022
Q3 | – | Sell |
-46
| Closed | -$22K | – | 6690 |
|
|
2022
Q2 | $22K | Buy |
+46
| New | +$22K | ﹤0.01% | 5696 |
|
|
2021
Q3 | – | Sell |
-13
| Closed | -$44K | – | 7068 |
|
|
2021
Q2 | $44K | Buy |
13
+3
| +30% | +$10.2K | ﹤0.01% | 6225 |
|
|
2021
Q1 | $30K | Sell |
10
-7
| -41% | -$21K | ﹤0.01% | 6162 |
|
|
2020
Q4 | $51K | Buy |
+17
| New | +$51K | ﹤0.01% | 4850 |
|
|
2020
Q3 | – | Sell |
-13
| Closed | -$18K | – | 5251 |
|
|
2020
Q2 | $18K | Buy |
+13
| New | +$18K | ﹤0.01% | 4499 |
|
|
2019
Q4 | – | Sell |
-15
| Closed | -$29K | – | 5111 |
|
|
2019
Q3 | $29K | Buy |
15
+9
| +150% | +$17.4K | ﹤0.01% | 4458 |
|
|
2019
Q2 | $14K | Buy |
+6
| New | +$14K | ﹤0.01% | 4531 |
|
|
2019
Q1 | – | Sell |
-7
| Closed | -$14K | – | 5018 |
|
|
2018
Q4 | $14K | Buy |
+7
| New | +$14K | ﹤0.01% | 4356 |
|
|
2018
Q1 | – | Sell |
-3
| Closed | -$43K | – | 4401 |
|
|
2017
Q4 | $43K | Hold |
3
| – | – | ﹤0.01% | 3649 |
|
|
2017
Q3 | $30K | Buy |
3
+2
| +200% | +$20K | ﹤0.01% | 3469 |
|
|
2017
Q2 | $30K | Hold |
1
| – | – | ﹤0.01% | 3450 |
|
|
2017
Q1 | $19K | Buy |
+1
| New | +$19K | ﹤0.01% | 3537 |
|
|
2016
Q2 | – | Hold |
0
| – | -$30K | – | 3884 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3085 |
|